Mepolizumab/omalizumabLack of efficacy following off-label use

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 1998卷 / 1期

关键词：

D O I：

10.1007/s40278-024-54140-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：296 / 296

相关论文

共 50 条

[41] CabazitaxelLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 102 - 102
[42] Multiple drugsLack of efficacy, and pneumonitis following off-label use
Reactions Weekly, 2024, 2017 (1) : 345 - 345
[43] SevofluraneLack of efficacy and off-label use
Reactions Weekly, 2024, 2012 (1) : 324 - 324
[44] EmapalumabLack of efficacy and off-label use
Reactions Weekly, 2024, 2004 (1) : 185 - 185
[45] MolnupiravirLack of efficacy and off-label use
Reactions Weekly, 2024, 2005 (1) : 546 - 546
[46] CortisoneLack of efficacy and off-label use
Reactions Weekly, 2024, 2016 (1) : 148 - 148
[47] SecukinumabLack of efficacy and off-label use
Reactions Weekly, 2024, 2008 (1) : 317 - 317
[48] NivolumabLack of efficacy and off-label use
Reactions Weekly, 2024, 2005 (1) : 653 - 653
[49] GlofitamabLack of efficacy and off-label use
Reactions Weekly, 2024, 2010 (1) : 182 - 182
[50] FavipiravirLack of efficacy and off-label use
Reactions Weekly, 2024, 2009 (1) : 256 - 256

← 1 2 3 4 5 →